Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat

被引:92
作者
Manusama, ER
Nooijen, PTGA
Stavast, J
Durante, NMC
Marquet, RL
Eggermont, AMM
机构
[1] UNIV ROTTERDAM HOSP,DR DANIEL DENHOED CANC CTR,DEPT SURG,ROTTERDAM,NETHERLANDS
[2] UNIV NIJMEGEN,DEPT PATHOL,NIJMEGEN,NETHERLANDS
关键词
D O I
10.1002/bjs.1800830438
中图分类号
R61 [外科手术学];
学科分类号
摘要
The efficacy of isolated limb perfusion (ILP) for 'in-transit' metastases from malignant melanoma and irresectable soft tissue sarcoma has been improved considerably by the addition of tumour necrosis factor (TNF) alpha. A rat sarcoma tumour model was, therefore, developed to evaluate the effects of TNF-alpha, melphalan and the combination of these drugs in the treatment of sarcoma. In BN rats bearing the non-immunogenic BN 175 sarcoma ILPs were performed with perfusate only, TNF-alpha, melphalan alone, or in combination when tumours had grown to approximately 1.5 cm in diameter. All rats treated with sham perfusion or perfusion with 50 mu g TNF-alpha showed progressive disease. After perfusion with 40 mu g melphalan no change in tumour diameter was observed in any rats at 4 days. After a combined perfusion with 40 mu g melphalan and 50 mu g TNF-alpha complete remission was noted in 12 of 16 rats. This synergistic effect in vivo between relatively ineffective doses of TNF-alpha and melphalan was not observed in vitro.
引用
收藏
页码:551 / 555
页数:5
相关论文
共 34 条
[21]  
LIENARD D, 1994, MELANOMA RES, V4, P21
[22]   HIGH-DOSE RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA IN COMBINATION WITH INTERFERON-GAMMA AND MELPHALAN IN ISOLATION PERFUSION OF THE LIMBS FOR MELANOMA AND SARCOMA [J].
LIENARD, D ;
EWALENKO, P ;
DELMOTTE, JJ ;
RENARD, N ;
LEJEUNE, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :52-60
[23]  
MANUSAMA ER, 1994, REG CANC TREAT, V7, P155
[24]   EFFECT OF TREATMENT WITH INTERFERON AND CYCLOPHOSPHAMIDE ON THE GROWTH OF A SPONTANEOUS LIPOSARCOMA IN RATS [J].
MARQUET, RL ;
SCHELLEKENS, H ;
WESTBROEK, DL ;
JEEKEL, J .
INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (02) :223-226
[25]   TUMOR NECROSIS FACTOR CACHECTIN-INDUCED INTRAVASCULAR FIBRIN FORMATION IN METH-A FIBROSARCOMAS [J].
NAWROTH, P ;
HANDLEY, D ;
MATSUEDA, G ;
DEWAAL, R ;
GERLACH, H ;
BLOHM, D ;
STERN, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (02) :637-647
[26]  
PREHN RT, 1957, J NATL CANCER I, V18, P769
[27]  
PROGRABNIAK HW, 1994, ANN THORAC SURG, V57, P1477
[28]   VWF RELEASE AND PLATELET-AGGREGATION IN HUMAN-MELANOMA AFTER PERFUSION WITH TNF-ALPHA [J].
RENARD, N ;
NOOIJEN, BTGA ;
SCHALKWIJK, L ;
DEWAAL, RMW ;
EGGERMONT, AMM ;
LIENARD, D ;
KROON, BBR ;
LEJEUNE, FJ ;
RUITER, DJ .
JOURNAL OF PATHOLOGY, 1995, 176 (03) :279-287
[29]   EARLY ENDOTHELIUM ACTIVATION AND POLYMORPHONUCLEAR CELL INVASION PRECEDE SPECIFIC NECROSIS OF HUMAN-MELANOMA AND SARCOMA TREATED BY INTRAVASCULAR HIGH-DOSE TUMOR-NECROSIS-FACTOR-ALPHA (RTNF-ALPHA) [J].
RENARD, N ;
LIENARD, D ;
LESPAGNARD, L ;
EGGERMONT, A ;
HEIMANN, R ;
LEJEUNE, F .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (05) :656-663
[30]  
Spriggs D. R., 1992, TUMOR NECROSIS FACTO, P383